This study is currently not recruiting participants.

A Randomized controlled Trial of the Effect of Hydrocortisone on Survival without Bronchopulmonary Dysplasia and on Neurodevelopmental Outcomes at 22-26 Months of Age in Intubated Infants

Investigating the Effects of an Investigational Medication on Infants with Breathing Support

Not Recruiting
1 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to find out whether giving hydrocortisone to infants who are on a breathing machine can help get them off this machine and lower their risk of getting bronchopulmonary dysplasia.

The National Institute of Child Health and H

Detailed description of study

The purpose of this study is to find out whether giving hydrocortisone to infants who are on a breathing machine can help get them off this machine and lower their risk of getting bronchopulmonary dysplasia.

The National Institute of Child Health and H

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Bronchopulmonary Dysplasia
  • Age: 1 years or below
  • Gender: All

This study investigates the effects of an investigational medication on infants who require a breathing machine. The purpose is to determine if this medication can help infants stop using the machine and reduce the risk of developing bronchopulmonary dysplasia, a lung condition common in premature infants.

Participants in the study will receive either the investigational medication or a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine. This will help researchers compare the outcomes between the two study arms.

  • Who can participate: Infants who require breathing support and are at risk of bronchopulmonary dysplasia are eligible. Specific age criteria and other eligibility factors will be determined by the study team.
  • Study details: Participants will receive either the investigational medication or a placebo.
Updated on 19 Feb 2024. Study ID: 1107006380

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team